MYOM2 and plasma cell myeloma: One study demonstrated that 99mTc-VHHs and SPECT/micro-CT successfully real-time monitor the expression change of M-protein in a mice model with multiple myeloma, with high uptake in M-protein expressing malignant plasma cells in the blood and no uptake in healthy mice (38).